Vimarsana
Biggest News Aggregation in the World

Page 37 - Jack Weinstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack Weinstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Weinstein Today - Breaking & Trending Today

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. S - Vimarsana News

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. S

Relief Therapeutics Holding SA / Key word(s): Miscellaneous04-Jul-2022 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Secur...

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency - Vimarsana News

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval04-Jul-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergen...

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission - Vimarsana News

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20...

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 21-Jun-2022